Optimal duration of G-CSF prophylaxis after docetaxel (D) + epirubicin (E) in metastatic breast cancer (MBC): Prediction using a mathematical model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback